Dashori 70mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Dasatinib (70mg)
Overview Dashori 70mg Tablet
Leukemia (chronic myeloid leukemia) is treated with the medication Dashori 70mg Tablet. It's prescribed for patients whose leukemia hasn't responded to other treatments or who can't tolerate those treatments due to adverse reactions. Dashori 70mg Tablets may be taken with or without food, but consistent daily timing maximizes effectiveness. Dosage and frequency are determined by your physician, depending on your condition and may be adjusted. Always adhere to your doctor's instructions; incorrect usage or overdose can lead to severe complications. While therapeutic effects might not be immediately apparent (weeks or months may pass), discontinue use only under medical guidance. Common side effects include nausea, vomiting, abdominal pain, and skin rash. Increased heart rate and blood pressure fluctuations (high or low) are possible; consult your doctor if these occur. Regular blood pressure monitoring may be necessary. Avoid antacids within two hours of taking this medication. This medication can lower blood cell counts, increasing infection risk; regular blood tests are essential. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or visual disturbances occur.
Uses of Dashori 70mg Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Dashori 70mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Dashori 70mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dashori 70mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Dashori 70mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 70mg Dashori Tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
How Dashori 70mg Tablet works:
Oncaspar 70mg tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus impeding or reducing cancerous growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dashori 70mg Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Employing Dashori 70mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. Exceptions may exist in critical medical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek professional medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should not use Dashori 70mg tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Dashori 70mg Tablets, such as dizziness or blurred vision. Exercise caution while driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Dashori 70mg Tablets in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely take Dashori 70mg tablets without requiring a change in dosage.
What if you forget to take Dashori 70mg Tablet :
Omit any missed Dashori 70mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Dashori 70mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently